Background
Warfarin is the most commonly prescribed oral anticoagulant for the prevention and treatment of venous thromboembolism associated with chronic atrial fibrillation and mechanical heart valves [1] . Due to its narrow therapeutic index, warfarin requires regular monitoring of the international normalized ratio (INR) to ensure proper anticoagulation control [2] . The INR therapeutic range for anticoagulation therapy is between 2.0 and 3.0, except for mechanical heart valves, which require an INR between 2.5 and 3.5. INRs outside of this range are strongly associated with an increased risk of major bleeding, thromboembolic events, and even death [3] .
Laboratory monitoring of warfarin therapy, known as usual care, includes repeated venous punctures to obtain INR results and subsequent dose adjustments by the health care provider [4] .
Using conventional measures, frequency of INR monitoring is problematic in ambulatory care. A research study showed that gaps in monitoring during warfarin therapy are associated with poor anticoagulation control and adverse events [5] . The data related gaps to non-adherence with INR monitoring and identified patient-level predictors, which included poverty, driving distance, dementia, depression, and nonwhite race. Another study evaluated patient nonadherence to standard INR testing and found that the rate of thromboembolic events was higher in the non-adherent group compared to the adherent group [6] . Non-adherence to INR monitoring is a common and significant barrier to proper anticoagulation control.
The option of patient self-testing (PST) using a point-of-care (POC) device has eliminated some of these barriers by enabling patients to test their INR levels at home via a fingerstick blood sample, compared to outpatient visits to a laboratory or clinic. The POC device communicates the INR result to the patient's provider wirelessly, through a secured website, and the provider adjusts the patient's warfarin dose accordingly. Another option of patient self-management (PSM) is available, in which patients are trained to self-test and interpret the INR result for dose adjustment. Systematic reviews have shown PST/PSM to be superior to usual care with fewer bleeding events and thromboembolic events, as well as reduced overall mortality [7] [8] [9] [10] [11] .
Therefore, evidence-based clinical practice guidelines recommend PST/PSM to all suitable patients receiving oral anticoagulation therapy [3, 12] . In this study, PST alone was implemented and its effects analyzed.
Methods

Scope of the Problem
In January 2010, the clinical problem of non-therapeutic INRs in patients receiving warfarin therapy was identified at a private practice setting in the southwest region of the United States. The scope of the problem was appreciated after collecting INR results from contracted laboratories over a 15-month period and calculating the average INR per quarter, or every three months. Infrequent and inconsistent INR testing was the main factor contributing to nontherapeutic levels. Therefore, PST was proposed as a solution to the problem.
Patient Recruitment
The practice setting's providers offered PST to patients if they met the following inclusion criteria: indication for long-term warfarin therapy, such as chronic atrial fibrillation, mechanical heart valve, and/or history of deep vein thrombosis; taking warfarin for at least 6 months; and willingness to participate in PST. Exclusion criteria included inability to perform the test, due to factors such as poor coordination with hand tremor or poor visual acuity, and denial of health insurance coverage for the device and PST-related billing expenses.
Training
Providers referred eligible patients to the practice setting's nurse practitioner who provided hands-on device training during a 45-minute consultation appointment. At the end of the appointment, the nurse practitioner assessed the patient's competency via a return demonstration. At the conclusion of the visit, the nurse practitioner provided the patient with a meter reference manual as well as contact information if questions or problems occurred.
Online System
Once the POC device was received, all participating patients were instructed to test their INR level at least once a week for the first month, or until therapeutic, and biweekly thereafter.
INR results were communicated to the provider via fax, phone call, and wirelessly through a secured online system. If the result was above or below the prescribed therapeutic range, the online system alerted the provider via phone call, requesting the provider to contact the patient within 24 hours for warfarin dose adjustment. Provider telephone support was available to the patients at all times.
Patients and providers were able to access the online system to view INR results. The system also stored patient information such as demographics, indication for therapy, insurance carrier information, provider, and past INR results. Information was only available to patients and providers through a password-protected website.
Data Collection
Patient data were collected and analyzed from January 2010 to September 2014. Patient data, including age, gender, indication for warfarin therapy, INR results, provider, and insurance carrier, were collected from electronic medical records. Regardless of each patient's start date, INR results were collected for at least six months before and after PST implementation. Using Microsoft excel, INR results were organized by pre and post-PST implementation and the averages were calculated every three months (quarterly) for data concision. INR averages were analyzed using QI Macros software and X-bar-S control charts were created.
Results
Of the 36 patients recruited for this project from January 2010 to September 2014, eight patients were excluded due to PST noncompliance, no longer being patients of the practice, or death. A total of twenty-eight patients remained and were included in the analysis. 
Discussion
The results of this analysis provide insight to the quality of INR control in patients who self-test, as well as the clinical efficacy of warfarin therapy. Additionally, the data from the analysis allows a comparison of the quality of INR control between PST and usual care.
Since major adverse events and death could not be attributed to a confirmable cause in the data, no analysis on the rate of major thromboembolic or bleeding events could be completed.
Thus, it is not possible to compare the rate of events in this data to the rate of newer oral anticoagulants reported in studies. Furthermore, this analysis is based on data collected in clinical practice, not in the controlled setting of a randomized controlled trial.
The mean frequency of INR testing was higher in PST using metered monitoring (88 times) than in usual care using laboratory monitoring (9 times). Testing frequency is strongly correlated with INR control. Therefore, PST was found to be more efficient in maintaining INR control and potentially reducing major adverse and fatal events, compared to usual care.
Moreover, the frequency of critical INR values is an important indicator of the effectiveness of warfarin therapy. Critical INR values are defined as those below 1.5, carrying a major risk of a thromboembolic event, and those above 5.0, carrying a major risk for a bleeding event [13, 14] .
In Figure 1 , the frequency of near-critical values is observed in the laboratory (usual care) data set with the lower control limit of 1.6. There are no critical values seen in the metered (PST) data set as the lower and upper control limits are within therapeutic range, 2.1 and 2.8, respectively. This suggests that PST is able to achieve tighter INR control within the defined therapeutic range of 2.0 to 3.0.
Conclusion
Overall, this project showed that PST was clinically more effective in INR monitoring than usual care in our internal medicine practice. PST achieved tight INR control within therapeutic range, improved therapeutic efficacy of warfarin, and enhanced treatment safety for patients. Thus, PST should be offered and recommended as a vital element of INR monitoring of long-term warfarin therapy.
EFFECTIVENESS OF INR PATIENT SELF-TESTING: ADULTS ON WARFARIN THERAPY IN INTERNAL MEDICINE
PURPOSE:
To compare the clinical effectiveness of INR patient self-testing in adults on warfarin therapy versus usual care in an internal medicine practice.
BACKGROUND:
Warfarin is the most commonly prescribed oral anticoagulant for the prevention and treatment of venous thromboembolism. Due to its narrow therapeutic index, warfarin requires close monitoring of the international normalized ratio (INR) to ensure proper anticoagulation control and safety. INRs outside of this range are strongly associated with an increased risk of major bleeding, thromboembolic events and even death. Patient self-testing (PST) using a point-of-care device allows patients to monitor their INR results from home. Evidence shows that PST improves the clinical outcomes of warfarin therapy compared to usual care, which includes laboratory INR monitoring.
METHODS:
Included competent and motivated adult patients with AF and/or DVT taking warfarin therapy for at least 6 months. Excluded those unable to self-test or denied health insurance coverage for PSTrelated expenses. The clinic Nurse Practitioner provided hands-on meter training and set-up to eligible patients. Competency and willingness to participate were assessed. Age, gender, insurance carrier, provider, indication for warfarin therapy and INR results were collected from January 2010 to September 2014. Quarterly INR averages (every 3 months) were calculated for data concision using Microsoft Excel. Control charts were created using QI Macros to compare laboratory INR data (usual care) to meter INR data (PST).
OUTCOMES:
In laboratory (usual care) monitoring, control limits are wide and INR results are variable, no statistically significant INR averages resulted. In meter (PST) monitoring, control limits are narrow and INR results are tightly controlled, resulting in statistically significant INR averages.
CONCLUSIONS:
Compared to usual care, PST resulted in tighter control of patients' INR measurements within a desirable range. PST provides a consistent process as well as a higher frequency of INR testing. As recommended by evidence-based practice guidelines, PST should be offered to suitable patients.
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